Cybil Roehrenbeck: “Reimbursement for AI medical services is available, but the pathway is uncertain.”

Cybil Roehrenbeck, partner at Hogan Lovells and executive director of the AI Healthcare Coalition, speaks to RevCycle Management about the reimbursement challenges facing health AI.

Cybil explains how outdated payment systems are slowing the adoption of AI medical services, despite FDA clearance and strong clinical demand. She outlines the hurdles developers face in both outpatient and inpatient settings, and how regional payment inconsistencies further complicate access.